Jiangxi Sanxin Medtec Co Ltd
SZSE:300453
Jiangxi Sanxin Medtec Co Ltd
Income from Continuing Operations
Jiangxi Sanxin Medtec Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jiangxi Sanxin Medtec Co Ltd
SZSE:300453
|
Income from Continuing Operations
¥233.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Income from Continuing Operations
¥2.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Income from Continuing Operations
¥830.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
21%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Income from Continuing Operations
¥1.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Income from Continuing Operations
¥628.5m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Income from Continuing Operations
¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
See Also
What is Jiangxi Sanxin Medtec Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
233.2m
CNY
Based on the financial report for Mar 31, 2024, Jiangxi Sanxin Medtec Co Ltd's Income from Continuing Operations amounts to 233.2m CNY.
What is Jiangxi Sanxin Medtec Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
43%
Over the last year, the Income from Continuing Operations growth was 19%. The average annual Income from Continuing Operations growth rates for Jiangxi Sanxin Medtec Co Ltd have been 15% over the past three years , 43% over the past five years .